Pharma Equity Group A/S
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PEG.CO research report →
About the company
Operating from Hørsholm, Denmark, Pharma Equity Group A/S is an investment firm primarily focused on the life sciences industry. The company strategically provides early-stage capital to ventures that are developing advanced technologies and treatments designed to improve human health and elevate the quality of life.
- CEO
- Christian Henrik Tange
- IPO
- 2023
- Employees
- 2
- HQ
- Horsholm, DK
Price Chart
- Market Cap
- $104.34M
- P/E
- -4.11
- P/S
- 0.00
- P/B
- 4.10
- EV/EBITDA
- -4.48
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -68.28%
- ROIC
- -72.48%
- Revenue
- $0 · 0.00%
- Net Income
- $-25,382,000 · -3.93%
- EPS
- $-0.02 · 9.61%
- Op Income
- $-25,288,000
- FCF YoY
- 100.00%
- 52W High
- $0.15
- 52W Low
- $0.06
- 50D MA
- $0.08
- 200D MA
- $0.10
- Beta
- 1.03
- Avg Volume
- 691.74K
Get TickerSpark's AI analysis on PEG.CO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our PEG.CO coverage
Recent articles, reports, and earnings notes.
No research on PEG.CO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PEG.CO report →Similar companies
Peers in the same neighborhood.